160 related articles for article (PubMed ID: 33168837)
1. Characterization of glycosphingolipids from gastrointestinal stromal tumours.
Santos L; Jin C; Gazárková T; Thornell A; Norlén O; Säljö K; Teneberg S
Sci Rep; 2020 Nov; 10(1):19371. PubMed ID: 33168837
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Glycosphingolipids in the Human Parathyroid and Thyroid Glands.
Säljö K; Thornell A; Jin C; Stålberg P; Norlén O; Teneberg S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208903
[TBL] [Abstract][Full Text] [Related]
3. Characterization of moose intestinal glycosphingolipids.
Johansson MM; Dedic B; Lundholm K; Branzell FB; Barone A; Benktander J; Teneberg S
Glycoconj J; 2015 Aug; 32(6):393-412. PubMed ID: 26104834
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Human Medullary Thyroid Carcinoma Glycosphingolipids Identifies Potential Cancer Markers.
Säljö K; Thornell A; Jin C; Norlén O; Teneberg S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638800
[TBL] [Abstract][Full Text] [Related]
5. Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts.
Barone A; Benktander J; Teneberg S; Breimer ME
Xenotransplantation; 2014; 21(6):510-22. PubMed ID: 25041314
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel nonacid glycosphingolipids as biomarkers of human gastric adenocarcinoma.
Jin C; Teneberg S
J Biol Chem; 2022 Apr; 298(4):101732. PubMed ID: 35176282
[TBL] [Abstract][Full Text] [Related]
8. Bacteria of the human intestinal microbiota produce glycosidases specific for lacto-series glycosphingolipids.
Falk P; Hoskins LC; Larson G
J Biochem; 1990 Sep; 108(3):466-74. PubMed ID: 2277039
[TBL] [Abstract][Full Text] [Related]
9.
Jin C; Barone A; Borén T; Teneberg S
J Biol Chem; 2018 Nov; 293(44):17248-17266. PubMed ID: 30232154
[No Abstract] [Full Text] [Related]
10. Glycosphingolipids of human plasma.
Kundu SK; Diego I; Osovitz S; Marcus DM
Arch Biochem Biophys; 1985 May; 238(2):388-400. PubMed ID: 3994380
[TBL] [Abstract][Full Text] [Related]
11. The glycosphingolipid composition of the human hepatoma cell line,Hep-G2.
Spitalnik PF; Danley JM; Burger SR; Spitalnik SL
Arch Biochem Biophys; 1989 Sep; 273(2):578-91. PubMed ID: 2549875
[TBL] [Abstract][Full Text] [Related]
12. Glycosphingolipid binding specificities of Neisseria meningitidis and Haemophilus influenzae: detection, isolation, and characterization of a binding-active glycosphingolipid from human oropharyngeal epithelium.
Hugosson S; Angström J; Olsson BM; Bergström J; Fredlund H; Olcén P; Teneberg S
J Biochem; 1998 Dec; 124(6):1138-52. PubMed ID: 9832619
[TBL] [Abstract][Full Text] [Related]
13. Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts.
Barone A; Benktander J; Whiddon C; Jin C; Galli C; Teneberg S; Breimer ME
Xenotransplantation; 2018 Sep; 25(5):e12406. PubMed ID: 29932253
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
15. Glycosphingolipids of skeletal muscle: I. Subcellular distribution of neutral glycosphingolipids and gangliosides in rabbit skeletal muscle.
Müthing J; Maurer U; Neumann U; Kniep B; Weber-Schürholz S
Carbohydr Res; 1998 Feb; 307(1-2):135-45. PubMed ID: 9658569
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
Hořejší K; Jin C; Vaňková Z; Jirásko R; Strouhal O; Melichar B; Teneberg S; Holčapek M
J Biol Chem; 2023 Mar; 299(3):102923. PubMed ID: 36681125
[TBL] [Abstract][Full Text] [Related]
17. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
Müthing J; Cacić M
Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
[TBL] [Abstract][Full Text] [Related]
18. Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography.
Abul-Milh M; Paradis SE; Dubreuil JD; Jacques M
Infect Immun; 1999 Oct; 67(10):4983-7. PubMed ID: 10496867
[TBL] [Abstract][Full Text] [Related]
19. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate recognition by enterohemorrhagic Escherichia coli: characterization of a novel glycosphingolipid from cat small intestine.
Teneberg S; Angström J; Ljungh A
Glycobiology; 2004 Feb; 14(2):187-96. PubMed ID: 14576169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
